Stock RSLS RESHAPE LIFESCIENCES INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company ReShape Lifesciences Inc.

Equities

RSLS

US76090R2004

Advanced Medical Equipment & Technology

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
0.1681 USD -1.41% Intraday chart for ReShape Lifesciences Inc. +2.50% -32.68%
Apr. 12 North American Morning Briefing : Big Banks Kick -2- DJ
Apr. 01 Transcript : ReShape Lifesciences Inc., Q4 2023 Earnings Call, Apr 01, 2024

Business Summary

ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.

Number of employees: 29

Sales per Business

USD in Million2022Weight2023Weight Delta
Minimally Invasive Medical Devices
100.0 %
11 100.0 % 9 100.0 % -22.79%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
82.2 %
9 82.1 % 7 82.2 % -22.71%
Europe
11.0 %
1 11.1 % 1 11.0 % -23.64%
Australia
6.1 %
1 6.1 % 1 6.1 % -23.55%
Rest of World
0.7 %
0 0.6 % 0 0.7 % -11.43%

Managers

Managers TitleAgeSince
Paul Hickey CEO
 Chief Executive Officer 59 20-01-31
Thomas Stankovich DFI
 Director of Finance/CFO 63 21-06-14
Dov Gal CMP
 Compliance Officer - -
Al Diaz COO
 Chief Operating Officer - 21-08-30
Nick Ansari PRN
 Corporate Officer/Principal 62 22-09-05

Members of the board

Members of the board TitleAgeSince
Gary Blackford BRD
 Director/Board Member 66 15-12-31
Dan Gladney CHM
 Chairman 70 15-10-31
Arda Minocherhomjee BRD
 Director/Board Member 70 21-06-14
Paul Hickey CEO
 Chief Executive Officer 59 20-01-31
Lori McDougal BRD
 Director/Board Member 62 15-06-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 95,388 0 0 88.83 %
Stock B 1 23,457,090 20,838,013 ( 88.83 %) 0

Shareholders

NameEquities%Valuation
Yair Schneid
10.49 %
2,461,000 10.49 % 452 824 $
Matthew J. Nachtrab
0.5706 %
133,853 0.5706 % 24 629 $
Two Sigma Securities LLC
0.3222 %
75,579 0.3222 % 13 907 $
Virtu Financial LLC
0.3135 %
73,532 0.3135 % 13 530 $
Citadel Securities GP LLC
0.3106 %
72,866 0.3106 % 13 407 $
G1 Execution Services LLC
0.2517 %
59,038 0.2517 % 10 863 $
Vanguard Group, Inc. (Subfiler)
0.2126 %
49,874 0.2126 % 9 177 $
BlackRock Institutional Trust Co. NA
0.1452 %
34,060 0.1452 % 6 267 $
Gesalcalá SA SGIIC
0.1110 %
26,031 0.1110 % 4 790 $
Lori McDougal
0.1033 %
24,224 0.1033 % 4 457 $

Company contact information

ReShape Lifesciences, Inc.

1001 Calle Amanecer

92673, San Clemente

+

http://www.reshapelifesciences.com
address ReShape Lifesciences Inc.(RSLS)

Sector

Healthcare
Healthcare Services
Healthcare Equipment & Supplies
Advanced Medical Equipment & Technology
Other Advanced Medical Equipment & Technology

Sales per region

Ratings for ReShape Lifesciences Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.1681 USD
Average target price
1 USD
Spread / Average Target
+494.88%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
RESHAPE LIFESCIENCES INC. Stock ReShape Lifesciences Inc.
-32.68% 3.94M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+8.78% 220B
DANAHER CORPORATION Stock Danaher Corporation
+8.24% 185B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+11.16% 133B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+26.12% 107B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+0.91% 62.91B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+16.21% 53.34B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-1.63% 47.71B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-1.11% 40.29B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+12.16% 39.57B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. RSLS Stock
  4. Company ReShape Lifesciences Inc.